Study of MR-based IGRT for Prostate Cancer
Single-arm Phase II Study of MR(Magnetic Resonance Imaging)-Based Image-guided Radiotherapy for Prostate Cancer
About This Trial
- This clinical trial is studying a method that uses detailed MRI scans to help guide radiation therapy precisely to prostate tumors.
- It is open to adults diagnosed with prostate cancer who are seeking treatment aimed at curing their cancer and are in relatively good overall health.
- Before considering this study, you should know that you must be able to safely have an MRI scan, which means people with certain metal implants cannot take part.
- Additionally, you may not be eligible if you have previously received radiation to your pelvic area or have had certain past prostate procedures.
More Information
- MR (Magnetic Resonance Imaging) - based IGRT (image-guided radiotherapy) for patients with prostate carcinoma.
Who Can Enroll
- Age Range: 18 years and older
- Gender: Male
- Who This Trial is For: This clinical trial is studying a method that uses detailed MRI scans to help guide radiation therapy precisely to prostate tumors.
Study Details
- Start Date: March 2016
- Lead Sponsor: University Hospital Tuebingen
Full Eligibility Criteria
Inclusion Criteria
- histologically proven prostate cancer
- indication for curative treatment
- ECOG performance scale 0-2
- Informed consent
Exclusion Criteria
- contraindications for curative treatment
- age<18year
- previous pelvic radiotherapy or prostatic treatment like TURP (transurethral resection of prostate), HIFU (high intensity focused ultrasound)
- serious comorbidity leading to inability for IGRT (image-guided radiotherapy)
- contraindications for MRI (Magnetic Resonance Imaging)
Treatments
- Radiation: IGRT